Pharmacogenomics in Renal Therapeutics
This session will discuss how genetic variations affect drug response in kidney patients. Learn how pharmacogenomics supports precision prescribing to minimize side effects and improve outcomes. Explore case studies where genotyping guided immunosuppressant and antihypertensive dosing in renal patients. Understand the impact of polymorphisms in drug-metabolizing enzymes and transporters on therapeutic efficacy. Delve into pharmacogenomic testing implementation in clinical nephrology practice. Gain insights into ongoing research and guidelines shaping the future of individualized renal pharmacotherapy.
Related Conference of Pharmacogenomics in Renal Therapeutics
October 29-30, 2026
14th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Paris, France

